You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雅各臣科研製藥(02633.HK)就中國內地市場與富利衞美訂立恢甲清獨家分銷協議
格隆匯 11-05 23:02

格隆匯11月5日丨雅各臣科研製藥(02633.HK)公告,公司全資附屬公司雅各臣藥業(香港)有限公司與Versailles B.V.(於荷蘭註冊成立的公司)全資附屬公司富利衞美有限公司(Vemedia Shine Limited)於2019年11月5日訂立獨家分銷協議,內容有關在中國內地市場以知名藥用護足品牌"恢甲清(Excilor)"營銷及分銷其系列產品。

富利衞美為發展迅速的着名消費者醫療護理公司,總部位於荷蘭迪門(Diemen),於若干歐洲國家經銷具領導地位的自用藥物品牌組合。富利衞美旗下廣受認可的品牌恢甲清,專注於藥用護足,在指甲感染治療方面的非處方藥物市場上享有優越地位。

根據該協議的條款及條件,富利衞美委任雅各臣作為其獨家分銷商,為期十年,以(其中包括)於中國內地市場營銷、銷售及分銷該等產品。通過藉助其市場網絡,雅各臣科研製藥旨在為恢甲清品牌於增長迅速的中國指甲及足部護理市場建立堅實的地位。

董事會預計,委任雅各臣作為該等產品的中國內地獨家分銷商,將可加強雅各臣科研製藥的產品組合,進一步鞏固其市場地位,於快速增長的中國市場中,針對品牌保健產品日益增加的消費需求中受惠。憑藉其市場滲透能力,雅各臣科研製藥的首要目標為發揮恢甲清品牌的價值及市場潛力,並藉助是次策略合作與富利衞美締造協同效應。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account